← All companies
ACADIA PHARMACEUTICALS INC
ACAD - CIK 0001070494
Market cap$3.64 B
Rank#1650
SEC filings1,357
The table below shows ACADIA PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $177.69M | $319.59M | $188.66M | $114.85M | $147.44M | $326.03M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $121.46M | $98.74M | $98.27M | $62.20M | $64.37M | $48.25M |
| Inventory | $111.37M | $91.69M | $40.45M | $11.56M | $14.10M | $9.68M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.